Related Experiment Video

Updated: Aug 26, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine

Eddy C Hsueh1, Donald L Morton

  • 1Roy E. Coats Research Laboratories, John Wayne Cancer Institute, 2200 Santa Monica Blvd., Santa Monica, CA 90404, USA.

Seminars in Cancer Biology
|March 6, 2004
PubMed

Insights

Canvaxin, a therapeutic cancer vaccine, shows prognostic significance as adjuvant treatment for stage III/IV malignant melanoma. Immune responses correlate with clinical outcomes, suggesting potential for monitoring treatment effectiveness.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • No FDA-approved cancer vaccines currently exist for malignant melanoma.
  • Antigen-based active immunotherapy shows promise as a complementary treatment.
  • Phase I/II trials report encouraging response rates and low toxicities for cancer vaccines.

Purpose of the Study:

  • To evaluate the prognostic significance of Canvaxin, a therapeutic polyvalent cancer vaccine, in patients with malignant melanoma.
  • To assess the efficacy of Canvaxin as a postoperative adjuvant treatment for various stages of melanoma.
  • To explore the correlation between immune and clinical responses to vaccine therapy.

Main Methods:

  • Analysis of cumulative data from the largest phase II clinical trial of any cancer vaccine (Canvaxin).
  • Univariate and multivariate analyses were performed on patient data.
  • Evaluation of Canvaxin in patients with stage II, III, and IV melanoma, including those with regional in-transit disease.

Main Results:

  • Canvaxin demonstrated prognostic significance as a postoperative adjuvant treatment for stage III and IV melanoma.
  • The vaccine showed promising results in patients after resection of stage II melanoma and those with regional in-transit disease.
  • A consistent correlation was observed between immune responses and clinical responses to Canvaxin therapy.

Conclusions:

  • Canvaxin shows potential as an adjuvant immunotherapy for malignant melanoma, particularly for stages II, III, and IV.
  • Immune parameters can potentially serve as indicators for monitoring patient response to Canvaxin therapy.
  • Further research into antigen-based active immunotherapy is warranted for melanoma treatment.

More Related Videos

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...